p. 14699−14709
2345-5055
Vol.9/No.11
p. 14710−14718
2345-5055
Vol.9/No.11
p. 14719−14725
2345-5055
Vol.9/No.11
0.05). Pearson correlation coefficient test showed gross motor had a statistically significant association with the child's age (p =0.24, r = 0.075), birth weight (p =0.47, r = 0.045), current weight (p =0.34, r = 0.061), and current height (p =0.30, r = 0.066).Conclusion: There was no statistically significant difference in the development of children born following ART and Spontaneous pregnancy. The gross motor had a statistically significant association with some demographic information of children.]]>
p. 14726−14736
2345-5055
Vol.9/No.11
p. 14737−14746
2345-5055
Vol.9/No.11
p. 14747−14755
2345-5055
Vol.9/No.11
p. 14756−14771
2345-5055
Vol.9/No.11
p. 14772−14782
2345-5055
Vol.9/No.11
p. 14783−14800
2345-5055
Vol.9/No.11
p. 14801−14811
2345-5055
Vol.9/No.11
p. 14812−14820
2345-5055
Vol.9/No.11
0.05). Neonatal Apgar score, death, and NICU admission rate or period were not significantly different between the two groups (p>0.05).Conclusion: Homecare for the selected PPROM women could be a suitable expectant strategy without compromising neonatal or maternal outcomes.]]>
p. 14821−14829
2345-5055
Vol.9/No.11
p. 14830−14841
2345-5055
Vol.9/No.11
p. 14842−14855
2345-5055
Vol.9/No.11
0.05).Conclusion: Based on the results, it can be said that teaching neuro-verbal planning strategies and cognitive-behavioral approach reduces depression, anxiety and stress in adolescents. And the effect of teaching neuro-verbal planning strategies and cognitive-behavioral approach on reducing depression, anxiety and stress in adolescents has been the same.]]>
p. 14856−14866
2345-5055
Vol.9/No.11
p. 14867−14876
2345-5055
Vol.9/No.11
p. 14877−14887
2345-5055
Vol.9/No.11
0.05).Conclusions: Our findings showed a significant association between respiratory symptoms, positive RT- PCR, and positive CT findings. But ICU admission, endotracheal intubation, and death were not significantly correlated with PCR, chest CT scan, and anti-COVID-19 antibodies]]>
p. 14888−14895
2345-5055
Vol.9/No.11
p. 14896−14906
2345-5055
Vol.9/No.11
p. 14907−14913
2345-5055
Vol.9/No.11